AU2001243526A1 - Adrenergic receptor overexpression in airway tissues for the treatment of airwayobstructive diseases - Google Patents

Adrenergic receptor overexpression in airway tissues for the treatment of airwayobstructive diseases

Info

Publication number
AU2001243526A1
AU2001243526A1 AU2001243526A AU4352601A AU2001243526A1 AU 2001243526 A1 AU2001243526 A1 AU 2001243526A1 AU 2001243526 A AU2001243526 A AU 2001243526A AU 4352601 A AU4352601 A AU 4352601A AU 2001243526 A1 AU2001243526 A1 AU 2001243526A1
Authority
AU
Australia
Prior art keywords
airwayobstructive
diseases
treatment
adrenergic receptor
receptor overexpression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001243526A
Inventor
Stephen Bryant Liggett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Cincinnati
Original Assignee
University of Cincinnati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Cincinnati filed Critical University of Cincinnati
Publication of AU2001243526A1 publication Critical patent/AU2001243526A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1787—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001243526A 2000-03-10 2001-03-09 Adrenergic receptor overexpression in airway tissues for the treatment of airwayobstructive diseases Abandoned AU2001243526A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18840400P 2000-03-10 2000-03-10
US60188404 2000-03-10
PCT/US2001/007522 WO2001067862A1 (en) 2000-03-10 2001-03-09 Adrenergic receptor overexpression in airway tissues for the treatment of airway obstructive diseases

Publications (1)

Publication Number Publication Date
AU2001243526A1 true AU2001243526A1 (en) 2001-09-24

Family

ID=22692999

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001243526A Abandoned AU2001243526A1 (en) 2000-03-10 2001-03-09 Adrenergic receptor overexpression in airway tissues for the treatment of airwayobstructive diseases

Country Status (3)

Country Link
US (1) US20040192625A1 (en)
AU (1) AU2001243526A1 (en)
WO (1) WO2001067862A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2581086C (en) 2004-09-14 2023-11-07 The Regents Of The University Of Colorado, A Body Corporate Method for treatment with bucindolol based on genetic targeting
WO2007014033A2 (en) * 2005-07-22 2007-02-01 The Regents Of The University Of Colorado, A Body Corporate Inhibition of extracellular signal-regulated kinase 1/2 as a treatment for cardiac hypertrophy and heart failure
WO2019112913A1 (en) * 2017-12-04 2019-06-13 The Board Of Trustees Of The Leland Stanford Junior University Beta-2 selective adrenergic receptor agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156503A (en) * 1997-03-03 2000-12-05 The Regents Of The University Of California Diagnosing asthma patients predisposed to adverse β-agonist reactions
EP1044268A1 (en) * 1997-12-30 2000-10-18 Max-Delbrück-Centrum Für Molekulare Medizin Novel sequence variants of the human beta2-adrenergic receptor gene and use thereof

Also Published As

Publication number Publication date
US20040192625A1 (en) 2004-09-30
WO2001067862A1 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
AUPQ302899A0 (en) Implants for the use in the treatment of aneurysmal disease
AU2001255724A1 (en) Non-invasive tissue characterization
AU5987000A (en) Corrective mesh for body tissues
AU2003225160A1 (en) "biosensor for dialysis therapy"
EP1105046A4 (en) Retinal tissue implantation instrument
AU2000274383A1 (en) Preparation for treating diseases of bone tissues
AU6078500A (en) Combination therapy for conditions leading to bone loss
AU2003290059A1 (en) Use of cd137 antagonists for the treatment of tumors
AU2001232787A1 (en) Airway alkalinization as therapy for airway diseases
AU2002236781A1 (en) Treatment for snoring
AU1878201A (en) Composition for the treatment of damaged tissue
AU2001251138A1 (en) Compositions and methods for tissue specific gene regulation therapy
AU2001243526A1 (en) Adrenergic receptor overexpression in airway tissues for the treatment of airwayobstructive diseases
AU2002253785A1 (en) Catheter and implants for the delivery of therapeutic agents to tissues
AU3004000A (en) Methods for the treatment of apolipoprotein e related diseases
AU4605500A (en) Medical membrane for stimulating tissue formation
AU2001260713A1 (en) Medical composition kit for treating lesioned abnormal tissue
AU2001271026A1 (en) Remedies for bone diseases
AU2136500A (en) Preparation for dental treatment
AU2683500A (en) Compositions for the treatment of pain
AU2002366297A1 (en) Chair for spinal therapy
AU2000272704A1 (en) Use of compounds for the treatment of obesity
AU2002350513A1 (en) Use of solasonine for the treatment of skin tumors
AU2001274446A1 (en) Vip-related peptides for the treatment of skin disorders
AU5759500A (en) Methods for ameliorating icthyosiform skin diseases